R Gil Selected Research

R Gil Research Topics

Disease

4	Schizophrenia (Dementia Praecox) 08/2013 - 03/2000
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2005 - 10/2000
2	Stroke (Strokes) 02/2005 - 11/2004
2	Parkinson Disease (Parkinson's Disease) 03/2004 - 02/2002
2	Headache (Headaches) 06/2002 - 12/2001
1	Lower Urinary Tract Symptoms 09/2019
1	Obstructive Sleep Apnea 09/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Myofibrillar Myopathy 10/2016
1	Substance-Related Disorders (Drug Abuse) 08/2013
1	Experimental Arthritis 09/2012
1	Rheumatoid Arthritis 09/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Seminoma 06/2007
1	Hodgkin Disease (Hodgkin's Disease) 06/2007
1	Cerebellar Ataxia (Dysmetria) 02/2007
1	Herpes Zoster Oticus (Geniculate Neuralgia) 09/2006
1	Cutaneous Leishmaniasis 06/2005
1	Visceral Leishmaniasis (Kala Azar) 06/2005
1	Inflammation (Inflammations) 02/2005
1	Hypertension (High Blood Pressure) 11/2004
1	Blood Vessel Dissection 01/2003
1	Dissection Internal Carotid Artery 01/2003
1	Hallucinations (Hallucination) 02/2002
1	Ischemia 12/2001
1	Amnesia (Dissociative Amnesia) 04/2001
1	Hemorrhage 01/2001
1	Cerebral Infarction 01/2001
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2001
1	Infarction (Infarctions) 11/2000
1	Pathologic Constriction (Stenosis) 10/2000
1	Stable Angina 10/2000
1	Thrombosis (Thrombus) 08/2000
1	Paraplegia (Spastic Paraplegia) 06/2000
1	Parkinsonian Disorders (Parkinsonism) 06/2000
1	Dyskinesias (Dyskinesia) 06/2000
1	Dystonia (Limb Dystonia) 06/2000
1	Dopa-responsive Dystonia 06/2000
1	Multiple Sclerosis 05/2000
1	Disease Progression 05/2000
1	Left Ventricular Outflow Obstruction 03/2000

Drug/Important Bio-Agent (IBA)

4	Dopamine (Intropin)FDA LinkGeneric 08/2013 - 03/2000
2	LipidsIBA 06/2005 - 02/2005
2	Levodopa (L Dopa)FDA LinkGeneric 02/2002 - 06/2000
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019
1	EnzymesIBA 01/2019
1	Protein AggregatesIBA 10/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 08/2013
1	RacloprideIBA 08/2013
1	Therapeutic UsesIBA 09/2012
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2012
1	Chaperonin 60IBA 09/2012
1	CytokinesIBA 09/2012
1	AutoantigensIBA 09/2012
1	Peptides (Polypeptides)IBA 09/2012
1	LigandsIBA 09/2012
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2009
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2009
1	Hormones (Hormone)IBA 01/2009
1	AndrogensIBA 01/2009
1	TungstenIBA 02/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2006
1	Carrier Proteins (Binding Protein)IBA 06/2005
1	AntigensIBA 06/2005
1	LDL CholesterolIBA 02/2005
1	CholesterolIBA 02/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2004
1	Antipsychotic Agents (Antipsychotics)IBA 10/2004
1	Olanzapine (Zyprexa)FDA Link 10/2004
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2004
1	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 10/2004
1	Apomorphine FDA Link 03/2004
1	N 30IBA 06/2002
1	Dopamine Agonists (Dopamine Agonist)IBA 02/2002
1	Retinaldehyde (Retinal)IBA 12/2001
1	IsotopesIBA 04/2001
1	AnticoagulantsIBA 01/2001
1	Vasodilator Agents (Vasodilators)IBA 10/2000
1	CilazaprilIBA 10/2000
1	PapaverineIBA 10/2000
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2000
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 10/2000
1	Guanosine Triphosphate (GTP)IBA 06/2000
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2000
1	Immunoglobulin M (IgM)IBA 05/2000
1	AntibodiesIBA 05/2000
1	Serotonin (5 Hydroxytryptamine)IBA 03/2000
1	Dichlorodiphenyldichloroethane (DDD)IBA 03/2000
1	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 03/2000

Therapy/Procedure

2	Continuous Positive Airway Pressure 09/2019 - 06/2002
2	Therapeutics 09/2006 - 03/2000
1	Radiotherapy 06/2007
1	Secondary Prevention 02/2005
1	Deep Brain Stimulation 03/2004
1	Heimlich Maneuver 01/2003
1	Sclerotherapy 11/2000
1	Percutaneous Coronary Intervention 10/2000
1	Stents 08/2000
1	Catheters 03/2000